Goldiam International (526729) Q4 23/24 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 23/24 earnings summary
20 Oct, 2026Executive summary
FY24 revenue grew 11% YoY to ₹6,167.5 mn; EBITDA was ₹1,282.2 mn and PAT ₹909.1 mn.
Audited FY24 consolidated revenue from operations was ₹60,286.98 lakh vs ₹53,318.43 lakh; net profit after minority interest and associates was ₹9,680.64 lakh vs ₹8,960.53 lakh.
Lab-grown diamond jewellery reached 49% of FY24 revenue versus 21% in FY23.
Statutory auditors issued unmodified opinions on the audited standalone and consolidated FY24 results.
Financial highlights
Q4 FY24 revenue was ₹1,513.3 mn, up 12% YoY; EBITDA rose 22% to ₹274.1 mn and PAT rose 10% to ₹177.6 mn.
Audited Q4 FY24 consolidated revenue from operations was ₹14,785.86 lakh vs ₹13,494.81 lakh; net profit after minority interest and associates was ₹1,606.00 lakh vs ₹1,800.72 lakh.
FY24 gross profit increased 3% to ₹2,081.6 mn; gross margin fell 259 bps to 33.8%, EBITDA margin fell 175 bps to 20.8%, and PAT margin fell 63 bps to 14.7%.
FY24 consolidated profit before tax was ₹12,209.48 lakh vs ₹11,746.75 lakh; total comprehensive income was ₹9,690.15 lakh vs ₹9,036.92 lakh.
FY24 standalone revenue from operations was ₹37,377.81 lakh vs ₹30,344.78 lakh; net profit was ₹5,930.88 lakh vs ₹5,687.58 lakh.
Outlook and guidance
The ₹1,200 mn order book at March 31, 2024, was expected to be executed over four to six months; e-commerce spot sales were excluded.
First 3–5 Erah stores were scheduled to open in Q3 FY25; a rollout blueprint was intended to support expansion beyond FY25.
Latest events from Goldiam International
- US headwinds pressured revenue, while margins improved and a ₹30 crore Middle-East order expanded reach.526729
Q1 23/24 - Q2 revenue rose 50% as lab-grown jewellery gained share despite margin pressure.526729
Q2 23/24 - Q3 standalone profit rose while consolidated revenue fell versus the prior-year quarter.526729
Q3 23/24 - Q1 income rose as lab-grown jewellery reached 68.4% of export mix.526729
Q1 24/25 - H1 earnings grew as lab-grown mix expanded, while shipment delays and inventory weighed.526729
Q2 24/25 - Q3 consolidated profit rose as LGD exports expanded; a Rs 1 interim dividend was declared.526729
Q3 24/25 - FY25 earnings grew as lab-grown jewellery reached 82% of Q4 export revenue.526729
Q4 24/25 - Consolidated Q1 profit rose YoY, while standalone profit eased.526729
Q1 25/26 - Record FY26 earnings, 88% lab-grown export mix and a proposed 1-for-3 bonus.526729
Q4 25/26